Crossmark

Hermansky-Pudlak syndrome type 2 manifests with fibrosing lung disease early in childhood

Crossref DOI link: https://doi.org/10.1186/s13023-018-0780-z

Published Online: 2018-03-27

Published Print: 2018-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Hengst, Meike

Naehrlich, Lutz

Mahavadi, Poornima

Grosse-Onnebrink, Joerg

Terheggen-Lagro, Suzanne

Skanke, Lars Høsøien

Schuch, Luise A.

Brasch, Frank

Guenther, Andreas

Reu, Simone

Ley-Zaporozhan, Julia

Griese, Matthias https://orcid.org/0000-0003-0113-912X
Funding

Funding for this research was provided by:

European Union’s Seventh Framework Program (305653)

German Center for lung research

German Center for lung research

European Cooperation in Science and Technology (A16125)

Curetis, Holzgerlingen, Germany
License Information

Text and Data Mining valid from 2018-03-27
More Information

Article History

Received: 13 November 2017

Accepted: 1 March 2018

First Online: 27 March 2018

Ethics approval and consent to participate

: The study was approved by the ethics committee of the Ludwig-Maximilians University of Munich (EK 111-13).

: Informed consent to report individual patient data was obtained by all patients old enough to consent, and their parents or guardians.

: The authors declare that they have no competing interests.

: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.